Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition

Tools

Item Type:	Article
Title:	Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition
Creators Name:	Allen, N.E., Key, T.J., Appleby, P.N., Travis, R.C., Roddam, A.W., Rinaldi, S., Egevad, L., Rohrmann, S., Linseisen, J., Pischon, T., Boeing, H., Johnsen, N.F., Tjonneland, A., Gronbaek, H., Overvad, K., Kiemeney, L., Bueno-de-Mesquita, H.B., Bingham, S., Khaw, K.T., Tumino, R., Berrino, F., Mattiello, A., Sacerdote, C., Palli, D., Quiros, J.R., Ardanaz, E., Navarro, C., Larranaga, N., Gonzalez, C., Sanchez, M.J., Trichopoulou, A., Travezea, C., Trichopoulos, D., Jenab, M., Ferrari, P., Riboli, E. and Kaaks, R.
Abstract:	Some studies suggest that elevated serum insulin-like growth factor (IGF)-I concentrations are associated with an increased risk of prostate cancer and, in particular, with an increased risk of advanced-stage prostate cancer.
Keywords:	Prospective, Prostate Cancer, Serum, IGF-I, IGFBP-3, EPIC
Source:	Cancer Epidemiology Biomarkers & Prevention
ISSN:	1055-9965
Publisher:	American Association for Cancer Research
Volume:	16
Number:	6
Page Range:	1121-1127
Date:	June 2007
Official Publication:	https://doi.org/10.1158/1055-9965.EPI-06-1062
PubMed:	View item in PubMed

Repository Staff Only: item control page